Transparency Market Research Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 – 2019
Published Date 2014-04-08
143 Page Report
Buy Now
Request Sample
Press Release
Synthetic Biology Market to Surge Ahead at 32.6% CAGR From 2013 - 2019 Supported by Healthcare Applications Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Synthetic Biology Market
REPORT DESCRIPTION
Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 – 2019 Synthetic biology is on the path to becoming a US$13.4 billion market by 2019, exhibiting a sharp CAGR of 32.6% between 2013 and 2019, estimates Transparency Market Research in its latest report. The report, titled “Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019�, puts the value of the market at US$1.8 billion in 2012.Synthetic biology is a process that utilizes biology and genetic engineering to produce artificial biological systems and devices. The process is proving to be especially pivotal in producing affordable medicines and improved nutritional products. The report zeroes in the following key factors that have shaped the growth curve of the global synthetic biology market: Increased government participation and investments being routed into scientific research as well as active initiatives taken by private players in R&D. Besides pharmaceutical and nutrition-related applications, synthetic biology has been used for mitigating the damaging effects of marine pollution. The process has been extensively applied for developing engineered microorganisms to limit oil spill damages. Additionally, researchers have successfully used synthetic biology to convert regular plastics into microplastics that can be re-used. With DNA sequencing prices taking a plunge, the synthetic biology market will gain momentum. However, the global synthetic biology market is still impeded by ethical issues relating to synthetic biology products. Browse the full Synthetic Biology Market Report @ : http://www.transparencymarketresearch.com/synthetic-biology-market.html
Synthetic Biology Market Segmentation by Product, Application, and Technology The TMR reports offers a highly detailed study of the global synthetic biology market by classifying it on three fronts: Application, products and technologies. By application, the synthetic biology market is classified according to sectors such as: Healthcare, chemicals, agriculture and others. Of these, the healthcare segment will demonstrate continued growth thanks to factors such synthetic DNA and genes now being commercially available, which in turn supports the development of affordable pharma products.
Transparency Market Research
2
Synthetic Biology Market
Browse the full Synthetic Biology Market Press Release @ :http://www.transparencymarketresearch.com/pressrelease/synthetic-biologymarket.htm The segmentation of the synthetic biology market by product has been done as follows: Core products and enabling products. The core products segment is further segregated as: XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. The enabling products segment, on the other hand, is further divided into products for oligonucleotide synthesis and those for DNA synthesis. According to 2012 estimates, the core products segment enjoyed a larger share of market revenues as compared to enabling products. Based on the type of technology used in synthetic biology processes, the market is segmented as: Biological components and integrated systems, genome engineering, bioinformatics, and DNA sequencing. Technology for synthetic biology genome engineering is observed to be the most widely used as of 2012, because it can efficiently modify specific areas within the DNA to attain better reproducibility.
Regional and Competitive Analysis of the Synthetic Biology Market Findings of the TMR report indicate that Europe will lead the synthetic biology market through the forecast period as a result of active government initiatives and milestones achieved by private players. North America followed Europe in terms of market share as of 2012 through the launch of innovative technologies. Players that yield maximum influence over the synthetic biology market are: DuPont, Inc., Bayer AG, Amyris, Inc., Ginkgo Bioworks, Royal DSM, and Life Technologies Corporation. Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=421
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation
Transparency Market Research
3
Synthetic Biology Market
1.3 Research Methodology 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019) 2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million) 2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Drivers 3.2.1.1 Rising demand for improved drugs and vaccines 3.2.1.2 Advancement in molecular biology 3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research 3.2.1.4 Increasing demand of genetically modified crops due to rising population 3.3 Market Restraints 3.3.1 Ethical Issues 3.4 Market Opportunities
Transparency Market Research
4
Synthetic Biology Market
3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts 3.5 Porter’s Five Force Analysis 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
Chapter 4 Global Synthetic Biology Market, by Products 4.1 Introduction 4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million) 4.2 Core Products 4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.2.2 Synthetic DNA 4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million) 4.2.3 Synthetic Genes 4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million) 4.2.4 Synthetic Cells 4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
Transparency Market Research
5
Synthetic Biology Market
4.2.5 XNA (Xeno Nucleic Acid) 4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million) 4.2.6 Chassis Organisms 4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million) 4.3 Enabling Products 4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million) 4.3.2 DNA Synthesis 4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million) 4.3.3 Oligonucleotide Synthesis 4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Synthetic Biology Market, by Technologies 5.1 Introduction 5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million) 5.2 Genome Engineering 5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.3 DNA Sequencing 5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.4 Bioinformatics
Transparency Market Research
6
Synthetic Biology Market
5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 5.5 Biological Components and Integrated Systems 5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million)
Chapter 6 Global Synthetic Biology Market, by Applications 6.1 Introduction 6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million) 6.2 Chemicals 6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million) 6.3 Healthcare 6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million) 6.4 Agriculture 6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million) 6.5 Others (Biosecurity, R&D, Energy and Environment) 6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Synthetic Biology Market, by Geography 7.1 Introduction 7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
Transparency Market Research
7
Synthetic Biology Market
7.2 North America 7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.3 Europe 7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia-Pacific 7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) 7.5 Rest of the World (RoW) 7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Competitive Landscape 8.1 Heat Map Analysis for Key Market Players 8.1.1 Amyris, Inc. 8.1.2 DuPont, Inc. 8.1.3 Royal DSM 8.1.4 Evolva Holding 8.1.5 Life Technologies Corporation 8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
Chapter 9 Recommendations 9.1 Market Strategy for Success
Transparency Market Research
8
Synthetic Biology Market
9.1.1 Focus on investing in research and development activities 9.1.2 Strategic alliance, mergers and acquisitions 9.2 Barriers to be Considered 9.2.1 Ethical issues associated with synthetic biology products
Chapter 10 Company Profiles 10.1 Agrivida, Inc. 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Portfolio 10.1.4 Business Strategies 10.1.5 Recent Developments 10.2 Amyris, Inc. 10.2.1 Company Profile 10.2.2 Financial Overview 10.2.3 Product Portfolio 10.2.4 Business Strategies 10.2.5 Recent Developments 10.3 Algenol Biofuels, Inc. 10.3.1 Company Overview
Transparency Market Research
9
Synthetic Biology Market
10.3.2 Financial Overview 10.3.3 Product Portfolio 10.3.4 Business Strategies 10.3.5 Recent Developments 10.4 ATG:biosynthetics GmbH 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Product Portfolio 10.4.4 Business Strategies 10.4.5 Recent Developments 10.5 Bayer AG 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Product Portfolio 10.5.4 Business Strategies 10.5.5 Recent Developments 10.6 Bristol-Myers Squibb 10.6.1 Company Overview 10.6.2 Financial Overview 10.6.3 Product Portfolio 10.6.4 Business Strategies
Transparency Market Research
10
Synthetic Biology Market
10.6.5 Recent Developments 10.7 BIONEER CORPORATION 10.7.1 Company Overview 10.7.2 Product Portfolio 10.7.3 Business Strategies 10.7.4 Recent Developments 10.8 Biosearch Technologies, Inc. 10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Product Portfolio 10.8.4 Business Strategies 10.8.5 Recent Developments 10.9 CBC Comprehensive Biomarker Center GmbH 10.9.1 Company Overview 10.9.2 Financial Overview 10.9.3 Product Portfolio 10.9.4 Business Strategies 10.9.5 Recent Developments 10.10 Cobalt Technologies 10.10.1 Company Overview 10.10.2 Financial Overview
Transparency Market Research
11
Synthetic Biology Market
10.10.3 Product Portfolio 10.10.4 Business Strategies 10.10.5 Recent Developments 10.11 DuPont, Inc. 10.11.1 Company Overview 10.11.2 Financial Overview 10.11.3 Product Portfolio 10.11.4 Business Strategies 10.11.5 Recent Developments 10.12 Evolva SA 10.12.1 Company Overview 10.12.2 Financial Overview 10.12.3 Product Portfolio 10.12.4 Business Strategies 10.12.5 Recent Developments 10.13 Exxon Mobil Corporation 10.13.1 Company Overview 10.13.2 Financial Overview 10.13.3 Product Portfolio 10.13.4 Business Strategies 10.13.5 Recent Developments
Transparency Market Research
12
Synthetic Biology Market
10.14 Ginkgo Bioworks 10.14.1 Company Overview 10.14.2 Financial Overview 10.14.3 Product Portfolio 10.14.4 Business Strategies 10.14.5 Recent Developments 10.15 GeneWorks Pty Ltd. 10.15.1 Company Overview 10.15.2 Financial Overview 10.15.3 Product Portfolio 10.15.4 Business Strategies 10.15.5 Recent Developments 10.16 Genomatica, Inc. 10.16.1 Company Overview 10.16.2 Financial Overview 10.16.3 Product Portfolio 10.16.4 Business Strategies 10.16.5 Recent Developments 10.17 GeneScript Corporation 10.17.1 Company Overview 10.17.2 Financial Overview
Transparency Market Research
13
Synthetic Biology Market
10.17.3 Product Portfolio 10.17.4 Business Strategies 10.17.5 Recent Developments 10.18 Gevo, Inc. 10.18.1 Company Overview 10.18.2 Financial Overview 10.18.3 Product Portfolio 10.18.4 Business Strategies 10.18.5 Recent Developments 10.19 Green Biologics Limited 10.19.1 Company Overview 10.19.2 Financial Overview 10.19.3 Product Portfolio 10.19.4 Business Strategies 10.19.5 Recent Developments 10.20 New England Biolabs, Inc. 10.20.1 Company Overview 10.20.2 Financial Overview 10.20.3 Product Portfolio 10.20.4 Business Strategies 10.20.5 Recent Developments
Transparency Market Research
14
Synthetic Biology Market
10.21 OriGene Technologies, Inc. 10.21.1 Company Overview 10.21.2 Financial Overview 10.21.3 Product Portfolio 10.21.4 Business Strategies 10.21.5 Recent Developments 10.22 REG Life Sciences, LLC 10.22.1 Company Overview 10.22.2 Financial Overview 10.22.3 Product Portfolio 10.22.4 Business Strategies 10.22.5 Recent Developments 10.23 Royal DSM 10.23.1 Company Overview 10.23.2 Financial Overview 10.23.3 Product Portfolio 10.23.4 Business Strategies 10.23.5 Recent Developments 10.24 Thermo Fisher Scientific, Inc. 10.24.1 Company Overview 10.24.2 Financial Overview
Transparency Market Research
15
Synthetic Biology Market
10.24.3 Product Portfolio 10.24.4 Business Strategies 10.24.5 Recent Developments List of Figures
FIG. 1 Synthetic Biology Market Segmentation FIG. 2 Global Synthetic Biology Market, by Technologies, 2012 (USD Million) FIG. 3 Comparative Analysis: Global Synthetic Biology Market, by Geography, 2012 and 2019 (Value %) FIG. 4 Porter’s Five Forces Analysis: Global Synthetic Biology Market FIG. 5 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography FIG. 6 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million) FIG. 7 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million) FIG. 8 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million) FIG. 9 Global XNA Market Revenue, 2014 – 2019 (USD Million) FIG. 10 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million) FIG. 11 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million) FIG. 12 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million) FIG. 13 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 14 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
16
Synthetic Biology Market
FIG. 15 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 16 Global Biological Components and Integrated Systems in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 17 Global Synthetic Biology in Chemicals Market Revenue, 2011 – 2019 (USD Million) FIG. 18 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million) FIG. 19 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million) FIG. 20 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million) FIG. 21 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 22 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 23 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 24 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million) FIG. 25 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013 FIG. 26 Amyris, Inc.: Annual Revenue, 2010 – 2012 (USD Million) FIG. 27 Bayer AG: Annual Revenue, 2011 – 2013 (USD Million) FIG. 28 Bristol-Myers Squibb: Annual Revenue, 2011 – 2013 (USD Million) FIG. 29 DuPont, Inc.: Annual Revenue, 2010– 2012 (USD Million) FIG. 30 Evolva SA: Annual Sales, 2010 – 2012 (USD Million), 1 CHF = 1.13 USD FIG. 31 Exxon Mobil Corporation: Annual Sales, 2010 – 2012 (USD Billion) FIG. 32 Gevo, Inc.: Annual Sales, 2010 – 2012 (USD Million) FIG. 33 Renewable Energy Group, Inc.: Annual Sales, 2011 – 2013 (USD Million)
Transparency Market Research
17
Synthetic Biology Market
FIG. 34 Royal DSM: Annual Revenue, 2010– 2012 (USD Million) FIG. 35 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million) List of Tables
TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Synthetic Biology Market (2012 & 2019) TABLE 3 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million) TABLE 4 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million) TABLE 5 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million) TABLE 6 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million) TABLE 7 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million) TABLE 8 U.S. Bio-fuels Pipeline Products, by Organizations TABLE 9 Developed Drugs and Vaccines Utilizing the Concept of Synthetic Biology TABLE 10 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million) TABLE 11 List of Organizations and their Synthetic Biology Products and Applications
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us
Transparency Market Research
18
Synthetic Biology Market
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
19